• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

WDI sees rebound in healthcare stocks

Article

For investors in healthcare stocks, 1995 was a much-needed shotin the arm that remedied a three-year period of falling shareprices. An annual survey by WDI Capital Markets of Hilton Head,SC, saw a strong surge in share prices among healthcare

For investors in healthcare stocks, 1995 was a much-needed shotin the arm that remedied a three-year period of falling shareprices. An annual survey by WDI Capital Markets of Hilton Head,SC, saw a strong surge in share prices among healthcare companieslast year. Vendors of cardiac instruments led the charge in stockvaluation growth, although manufacturers of medical imaging devicesturned in a strong performance as well.

For the year, overall healthcare industry share prices leaped40.1%, compared with a 4.7% decline in 1994. Share prices dropped9.4% in 1993 and 10.6% in 1992.

Among public imaging device companies, stock prices trackedby WDI climbed 75.8% in 1995, compared with a lackluster gainof 1.2% in 1994. ThermoTrex led the segment with share-price growthof 270%, while bone densitometry firm Hologic jumped 173%. Othervendors turning in strong performances for the year were bonedensitometry vendor Lunar, up 129%; image-guided catheter manufacturerEndosonics, up 122%; x-ray vendor Fischer Imaging, up 85%; andnuclear medicine firm ADAC Laboratories, up 55%.

Imaging services firms also enjoyed rising stock valuations,according to WDI's survey. Share prices in the segment rose anaverage of 52.2% for the year.

In other WDI news, the investment and advisory firm announcedthat former Fischer Imaging executive Robert Cascella has joinedthe company as president.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.